Skip to main content

Šárka Pospíšilová and her team awarded for Best Publications in 2021

Czech Medical Association of J.E. Purkyně Awarded the best scientific publications published in 2021. The prize for the best original work was awarded to Šárka Pospíšilová, MU Vice-Rector for Research and Doctoral Studies.

Vice-rector of MU Šárka Pospíšilová received the award for the best original work in Karolinum.

A team of scientists and clinicians led by Šárka Pospíšilová published several important original works in prestigious journals in the field of haematology (Blood, IF 25,4; Leukemia, IF 11,5) and in a renowned journal focused on molecular diagnostics (Journal of Molecular Diagnostics, IF 5,3). It was the set of these papers on the topic “Research and diagnosis of genetic changes in lymphoid leukemias and lymphomas and their significance for prognosis and therapy of the disease” that won the competition in the category of for the best original work.

She received the award for the set of works in Karolinum together with Michael Doubek, Department-vice head in the Department of Internal Medicine, Hematology and Oncology at the MU Faculty of Medicine.

Vice-Rector Šárka Pospíšilová

Key award-winning publications (4 additional papers published in 2021 as part of international collaborations were also included in the set):

1) Malčíková J., Pavlová Š., Kunt Vonková B., Radová L., Plevová K., Kotašková J., Pál K., Dvořáčková B., Ženatová M., Hynšt J., Ondroušková E., Panovská A., Brychtová Y., Závacká K., Tichý B., Tom N., Mayer J., Doubek M., Pospíšilová Š.: Low-burden TP53 mutations in CLL: Clinical impact and clonal evolution within the context of different treatment options. Blood (2021); 138(25):2670-2685. IF=25,4

2) Lobello C., Tichý B., Bystrý V., Radová L., Filip D., Mráz M., Montes-Mojarro IA., Prokoph N., Larose H., Liang HCh., Sharma G., Mologni L., Belada D., Kamaradová K., Fend F., Gambacorti-Passerini C., Merkel O., Turner S., Janíková A., Pospíšilová Š.: STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia (2021); 35(5): 1500-1505. IF=11,5

3) Navrkalová V., Plevová K., Hynšt J., Pál K., Marečková A., Reigl T., Jelínková H., Vrzalová Z., Stránská K., Pavlová Š., Panovská A., Janíková A., Doubek M., Kotašková J., Pospíšilová Š.: LYNX (LYmphoid NGS) panel: a comprehensive capture-based sequencing tool for the analysis of prognostic and predictive markers in lymphoid malignancies. The Journal of Molecular Diagnostics (2021); 23(8): 959-974. IF=5,3